Correction: Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.

Correction: Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.

[This corrects the article DOI: 10.1371/journal.pmed.1003323.].

Bibliographic Details
Main Author:	PLOS Medicine Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-09-01
Series:	PLoS Medicine
Online Access:	https://doi.org/10.1371/journal.pmed.1003774

Similar Items

Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.
by: Samuel A Danziger, et al.
Published: (2020-11-01)

Relationship Between Serum Periostin Level and Bone Marrow Fibrosis in Newly Diagnosed Multiple Myeloma Patients
by: Ali Kürşat TUNA, et al.
Published: (2023-06-01)

The Bone Marrow Microenvironment in Multiple Myeloma
by: Edwards, C
Published: (2010)

Correction: Three-Dimensional Microfluidic Tri-Culture Model of the Bone Marrow Microenvironment for Study of Acute Lymphoblastic Leukemia.
by: PLOS ONE Staff
Published: (2015-01-01)

Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment
by: Matthew Ho, et al.
Published: (2022-11-01)

Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma - Appendix
by: Richards, S, et al.
Published: (1999)

CHARACTERISTICS OF BONE MARROW MICROENVIRONMENT IN MULTIPLE MYELOMA BEFORE AND AFTER TREATMENT
by: V. I. Rugal, et al.
Published: (2019-03-01)

Editorial: The role of the bone marrow microenvironment in multiple myeloma evolution and therapy
by: Carolina Schinke, et al.
Published: (2023-02-01)

Targeted Approaches to Inhibit Sialylation of Multiple Myeloma in the Bone Marrow Microenvironment
by: Alessandro Natoni, et al.
Published: (2019-10-01)

The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors
by: Barry Paul, et al.
Published: (2020-08-01)

Correction: Splenocytes Seed Bone Marrow of Myeloablated Mice: Implication for Atherosclerosis.
by: PLOS ONE Staff
Published: (2015-01-01)

Bone-Related Extramedullary Disease in Newly Diagnosed Myeloma Patients is an Independent Poor Prognostic Predictor
by: Ying Wang, et al.
Published: (2022-07-01)

The R2-ISS in a Multicenter Cohort of Chinese Patients With Newly Diagnosed Multiple Myeloma
by: Peiyu Yang, et al.
Published: (2023-04-01)

The prognostic value of the MASS in a multi-center cohort of patients with newly diagnosed multiple myeloma
by: Peiyu Yang, et al.
Published: (2022-09-01)

Muscle and fat composition in patients with newly diagnosed multiple myeloma
by: Nadine H. Abdallah, et al.
Published: (2023-12-01)

Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas
by: Martin Stork, et al.
Published: (2022-10-01)

HOW I TREAT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS?
by: María-Victoria Mateos
Published: (2021-11-01)

Bone marrow adipocytes is a new player in supporting myeloma cells proliferation and survival in myeloma microenvironment
by: Xiaoqian Wei, et al.
Published: (2024-02-01)

The importance of the bone marrow microenvironment in multiple myeloma; Differential responses to lithium in vivo
by: Edwards, C, et al.
Published: (2006)

Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment
by: Raquel Lopes, et al.
Published: (2022-07-01)

Clinical significance of granule‐containing myeloma cells in patients with newly diagnosed multiple myeloma
by: Kazuhito Suzuki, et al.
Published: (2016-11-01)

Correction: Glutathione S-transferase P influences redox and migration pathways in bone marrow.
by: PLOS ONE Staff
Published: (2015-01-01)

High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients
by: Mengmeng Dong, et al.
Published: (2022-08-01)

PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients
by: Federica Costa, et al.
Published: (2021-01-01)

Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective Study.
by: Shang-Yi Huang, et al.
Published: (2015-01-01)

The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients
by: Michał Mielnik, et al.
Published: (2023-11-01)

The choice of regimens based on bortezomib for patients with newly diagnosed multiple myeloma.
by: Jingsong He, et al.
Published: (2014-01-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020-12-01)

Immunophenotypic Characteristics of Bone Marrow Microenvironment Cellular Composition at the Biochemical Progression of Multiple Myeloma
by: Agnieszka Krzywdzińska, et al.
Published: (2022-06-01)

Excessive serine from the bone marrow microenvironment impairs megakaryopoiesis and thrombopoiesis in Multiple Myeloma
by: Chunmei Kuang, et al.
Published: (2023-04-01)

Decreased bone marrow-derived adiponectin contributes to myeloma pathogenesis in vivo
by: Fowler, J, et al.
Published: (2010)

Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group
by: Jelena Bila, et al.
Published: (2021-08-01)

Acquired platelet dysfunction in newly diagnosed myeloma
by: Joshua Mortimer, et al.
Published: (2021-02-01)

Daratumumab in untreated newly diagnosed multiple myeloma
by: Nadine Abdallah, et al.
Published: (2019-12-01)

Hemophagocytic Lymphohistiocytosis Secondary to Hodgkin’s Lymphoma with Isolated Bone Marrow Involvement in a Newly Diagnosed HIV Patient
by: Alberto Lopez-Garcia, et al.
Published: (2023-07-01)

Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients
by: Priscilla Cury de Camargo Cury, et al.
Published: (2020-04-01)

Correction: association between cutaneous nevi and breast cancer in the nurses' health study: a prospective cohort study.
by: PLOS Medicine Staff
Published: (2015-03-01)

Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma Patients
by: Samrat Roy Choudhury, et al.
Published: (2021-12-01)

Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
by: Bei Wang, et al.
Published: (2022-10-01)

Efficiency of lenalidomide, bortezomib and prednisone (RVP) in patients with newly diagnosed multiple myeloma
by: K. A. Belousov, et al.
Published: (2019-04-01)